News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Features The Price of Knowledge: Industry-Sponsored Studies in the Era of Evidence-Based Medicine Shelley Wood October 22, 2018
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Daily News ‘Doomed’ by Genetics? Lifestyle Still Matters in Preventing CVD and Diabetes Yael L. Maxwell June 29, 2018
News Daily News New European Hypertension Guidelines Not in Harmony With US Guidance Todd Neale June 11, 2018
News Conference News EuroPCR 2018 Two Sham-Controlled Renal Denervation Studies Offer Hope in Hypertension Michael O'Riordan May 23, 2018
News Industry News ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris May 17, 2018
News Daily News Prominent Investigator Takes Post at Medtronic as Pivotal Renal Denervation Trial Is Announced Todd Neale April 12, 2018
News Conference News ACC 2018 ACC 2018: More PCSK9 Outcomes, Antiplatelet Insights, and LifeVest Data at Last Shelley Wood March 05, 2018
News Features Mercury Rising: As Doctors’ Groups Face Off Over BP Guidelines, Will Patients Fall Through the Cracks? L.A. McKeown February 26, 2018
News Daily News Roughly Half of Obese Patients Who Have Bariatric Surgery Are Off Type 2 Diabetes Meds at 6 Years Michael O'Riordan February 19, 2018
News Conference News ESC 2017 Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field Todd Neale August 28, 2017
News Features Be It Resolved: Lifestyle Changes for Patients Needing Cardiac Rehab May Be a Life or Death Matter Michael O'Riordan January 10, 2017
News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016